Kevin Li
InvestorPartner at Frazier Life Sciences Β· Principal at Frazier Healthcare Partners
Palo Alto
About
Kevin Li is a Partner at Frazier Life Sciences, which he joined in 2021, investing in public and late-stage private companies through the Frazier Life Sciences Public Fund. He previously worked as a consultant at McKinsey & Company on corporate strategy, growth, and M&A in hospital services and pharmaceuticals, and was a resident physician in Internal Medicine at Stanford. He holds an M.D. from Stanford University and a B.S. in Molecular Biophysics and Biochemistry from Yale University.
Invests in
Biotech
Experience
- Frazier Life SciencesPartnercurrent2021 β presentPalo Alto, California, United States
- Stanford Health CareResident Physician - Internal Medicine2020 β 2021Stanford, California, United States
- Frazier Healthcare PartnersSummer Associate2019
- Acuta Capital Partners, LLCSummer Associate2018
- McKinsey & CompanyBusiness Analyst2014 β 2016New York City Metropolitan Area
- Yale University School of MedicineResearch Assistant2011 β 2014New Haven, CT
Education
- Stanford University School of MedicineM.D.2016 β 2020
- Yale UniversityB.S., Molecular Biophysics and Biochemistry2010 β 2014
Same school
Also attended Stanford University School of Medicine71
+ 65 more
Also attended Yale University523
+ 517 more
Shared employers
Also worked at Frazier Life Sciences46
+ 40 more
Also worked at Stanford Health Care27
+ 21 more
Also worked at Frazier Healthcare Partners24
+ 18 more
Also worked at McKinsey & Company1,209
+ 1,203 more
Deals Β· 2
Scorpion TherapeuticsLed round
35PharmaLed round
Attribution from SEC filings, press coverage, and firm rosters.






























.jpg)







